8-K current report · filed Jun 8, 2026

GoHealth, Inc. (GOCO) 8-K Current Report: June 8, 2026

Item 1.03Item 2.04Item 5.02Item 7.01GOCO overviewOriginal on SEC EDGAR

Short answer

GoHealth, Inc. (GOCO) filed an 8-K current report with the SEC on June 8, 2026 reporting Item 1.03 (Bankruptcy or Receivership), Item 2.04 (Triggering Events That Accelerate or Increase a Direct Financial Obligation), Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). GoHealth and subsidiaries filed voluntary Chapter 11 bankruptcy on June 7, 2026, signaling severe balance-sheet distress.

  • This filing includes Item 1.03 and Item 2.04, items that often signal trouble.

Why these 8-K items matter →

GoHealth, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.03 · Bankruptcy or Receivership

  • GoHealth and subsidiaries filed voluntary Chapter 11 bankruptcy on June 7, 2026, signaling severe balance-sheet distress
  • Prepackaged restructuring plan supported by 100% of lenders and over 60% of Class A shareholders
  • Over 99% of GoHealth Holdings unit holders support the proposed plan, improving confirmation prospects
  • Operations continue under debtor-in-possession status during court-supervised restructuring
  • Plan confirmation and consummation remain uncertain, creating material recovery and equity-value risk

Item 2.04 · Triggering Events That Accelerate or Increase a Direct Financial Obligation

  • Chapter 11 filing triggered defaults under GoHealth’s 2025 Superpriority Credit Agreement and 2019 Credit Agreement
  • Outstanding principal and accrued interest became immediately due, including an invested-capital multiple under the Superpriority facility
  • Bankruptcy automatic stay blocks creditor enforcement while Chapter 11 proceedings continue
  • Reorganization Plan governs treatment and expected recoveries for claims under both debt agreements

Item 5.02 · Departure/Election of Directors or Officers

  • CEO Vijay Kotte received approximately $2.87 million tied to Chapter 11 performance milestones
  • Additional CEO cash awards depend on emergence and post-emergence performance through the ten-month performance period
  • Kotte forfeits unpaid and previously paid awards upon cause, resignation without good reason, or restrictive-covenant violation
  • Kotte waived his 2026 annual bonus and agreed emergence would not trigger change-in-control or good-reason claims
  • COO Michael Hargis departed June 5, 2026 without cause, triggering severance obligations under the April 30 proxy terms

Item 7.01 · Regulation FD Disclosure

  • Chapter 11 restructuring remains the central investor issue, with Bankruptcy Court approval and Plan confirmation still pending
  • Existing Class A holders and GoHealth Holdings unit holders face limited recovery and potential cancellation of equity interests
  • Class A common stock expected to be delisted from Nasdaq and potentially trade over-the-counter during bankruptcy
  • Successful Plan could trigger a change of control and eliminate existing holders’ ownership, voting and other rights
  • Bankruptcy process risks liquidity, counterparties, employees and operating continuity through delays and higher legal costs

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other GoHealth, Inc. 8-K filings

Get the next GOCO 8-K as it lands

Follow GOCO for push alerts, or ask the research agent what this filing means.